Human Amyloid Imaging

The 8th Human Amyloid Imaging meeting will take place in Miami, Florida on January 15-17, 2014. My co-organizers for the meeting will again be Bill Klunk and Chet Mathis (University of Pittsburgh) and Bill Jagust (University of California, Berkeley).

At HAI 2014 we will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions will primarily spring from brief presentations by active investigators who will report unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer's-related disease. To assemble at HAI only the most recent, important work, abstract submissions will be again accepted and peer-reviewed less than two months prior to the meeting.
+ show speakers and program
KEYNOTE SPEAKERS

Tom Beach, MD, Ph.D.
Thomas Beach is Head and Senior Scientist at the Civin Laboratory for Neuropathology, and Director of the Brain and Body Donation Program, both of which are located at Banner Sun Health Research Institute in Sun City, Arizona. Dr. Beach has degrees in Biology (BS), Neuroscience (PhD) and Medicine (MD) from the University of British Columbia (UBC) in Vancouver, Canada. He was trained in anatomic pathology and neuropathology at St. Louis University School of Medicine and at UBC. Dr. Beach has been the recipient of multiple grants and awards from agencies including the National Institutes of Health, Alzheimer’s Association, the Arizona Biomedical Research Commission and the Michael J. Fox Foundation for Parkinson’s Research. He is the Director of the National Brain and Tissue Resource for Parkinson’s Disease and Related Disorders and Neuropathology Core Leader for Arizona’s National Institute on Aging Alzheimer’s Disease Core Center and for the Arizona Parkinson’s Disease Consortium. He has served as a grants reviewer for the National Institutes of Health, the Veterans Administration and the Alzheimer’s Association. Dr. Beach’s research is focused on elucidating early pathologic stages and biomarkers of Parkinson’s disease and Alzheimer’s disease, through studies of normal human brain aging and animal models. He has published the results of numerous neuropathology and neuroscience investigations on these topics.



Eckhard Mandelkow studied physics and received his PhD at the Max-Planck-Institute for Medical Research in Heidelberg (for work on the structure of tobacco mosaic virus). Dr. Mandelkow completed postdoctoral training at Brandeis University, Waltham MA (structure of cytoskeletal proteins) and later moved to the Deutsches Elektronensynchrotron (DESY) in Hamburg, Germany, as director at the Max-Planck-Unit for Structural Molecular Biology and professor at Hamburg University.

His current research focuses on structural molecular biology by X-rays using synchrotron radiation, image reconstruction in electron microscopy, cytoskeleton (microtubules, motor proteins), the structure, function, and aggregation of tau protein and protein kinases in Alzheimer disease, and the development of tau aggregation inhibitors.

Dr. Mandelkow received the 2010 Metlife Award and a 2011 Potamkin Award. In 2011 he joined the German Center for Neurodegenerative Diseases in Bonn (DZNE) as a Principal Investigator.

15 Jan - 17 Jan 2014
Miami
United States of America
meeting website